P2X 7 is a receptor for extracellular nucleotides expressed by different normal cell types. P2X 7 triggering may result in stimulation of cell proliferation or induction of apoptosis depending on the level of activation. P2X 7 expression and function in B-cell chronic lymphocytic leukemia has been shown to correlate with disease severity. Here, we have asked the question of whether P2X 7 is expressed and functional in neuroblastoma, a pediatric tumor of neuroectodermal origin. P2X 7 was detected both in primary neuroblastoma tumors and in neuroblastoma cell lines. In the latter cells, P2X 7 stimulation by ATP was found to trigger (a) increased intracellular calcium fluxes, (b) plasma membrane depolarization, and (c) formation of a nonselective plasma membrane permeable pore. In contrast to the usual response typically observed in the majority of cell types, P2X 7 in vitro stimulation did not induce caspase-3 activation or apoptosis of neuroblastoma cells but rather supported their proliferation. Growth stimulation was partially due to substance P release from nucleotide-activated neuroblastoma cells. Therefore, neuroblastoma cells seem to have molded P2X 7 function to their advantage in two ways (i.e., by silencing P2X 7 proapoptotic activity and by coupling P2X 7 stimulation to release of locally acting trophic factors). (Cancer Res 2006; 66(2): 907-14) 
Introduction
Nucleotides are an ubiquitous family of extracellular signaling molecules that exert different effects through the interaction with plasma membrane receptors named P2 receptors (1) . According to the molecular structure, P2 receptors are subdivided into P2Y and P2X families (2) . The former were identified as sevenmembrane-spanning G protein-coupled receptors and the latter as multimeric ligand-gated plasma membrane ion channels that mediate transmembrane cation fluxes (3, 4) . Originally characterized in excitable cells, P2 receptors have been later identified in many cells of widely different origin (5, 6) . One of the P2X subtypes, P2X 7 , has attracted much interest for its unique behavior. Whereas transient stimulation with ATP causes the opening of the channel and the concomitant Ca 2+ and Na + influx and K + efflux, sustained stimulation with ATP induces the appearance of a large, nonselective membrane pore, which permeabilizes the cells to larger molecules (7) . This event results in cell apoptosis through the activation of metalloproteinases and caspases (8) . However, P2X 7 activation can also induce lymphocyte proliferation, because transfection of P2X 7 cDNA increases the proliferative capacity of lymphoid cells (9) . Additional events induced by long-term P2X 7 activation include the release of interleukin (IL)-1h, plasma membrane blebbing, and macrophage fusion (10) (11) (12) .
The P2X 7 receptor is expressed in normal hematopoietic cells, such as lymphocytes, dendritic cells, and macrophages (7) . Recent studies showed that P2X 7 is differentially expressed in neoplastic cells from patients with indolent B-cell chronic lymphocytic leukemia (B-CLL) versus progressive B-CLL courses (13) . In these latter cells, ATP had a strong cytotoxic effect (13) . Because no information is available about P2X 7 expression and function in tumor cells of different origin, we have here investigated these issues in human neuroblastoma cells.
Neuroblastoma is the most common extracranial tumor of childhood, derived from the sympathetic nervous system (14) . Whereas stage I and II tumors are localized and well differentiated and can usually be cured by surgical resection, only patients with stage III and IV tumors present regional and disseminated disease, respectively, often characterized by low response to conventional treatments and poor prognosis (14) .
In this study, we show that P2X 7 is expressed in neuroblastoma primary tumors and cell lines and that functional activation of this receptor by ATP is coupled to massive increase in cytosolic calcium, membrane depolarization, and uptake of larger hydrophilic molecules. Furthermore, we show that P2X 7 stimulation by ATP induces early morphologic changes without signs of apoptosis and late increase of cell proliferation mediated by substance P secretion.
Materials and Methods
Immunohistochemical staining of primary neuroblastoma tissues. This investigation was done after approval by a local institutional review board.
The criteria used for diagnosis and evaluation of disease extension have been reported elsewhere (15) . Briefly, diagnosis was based on histologic grounds or on bone marrow infiltration by tumor cells, usually associated with elevated urinary catecholamine excretion.
The disease was staged according to the criteria of the International Neuroblastoma Staging System (15) . They include the measurement of primary tumor size with ultrasonography and/or computed tomography, a bone marrow study by at least one aspirate, a skeletal study by plain X-ray survey and/or technetium 99 m DPM scintigraphy, and the measurement of urinary vanillylmandelic and homovanillic acids and of serum lactate dehydrogenase (15) .
The primary neuroblastic tumors used in this study were obtained from patients at diagnosis before the implementation of any therapy.
Tissue samples were fixed in 20% buffered formalin, routinely processed, and embedded in paraffin. Immunohistochemical staining of tissue sections was done using the Envision System Horseradish Peroxidase (HRP) Mouse (DAKO, Glostrup, Denmark) as described previously (16) . Briefly, 5-Amthick sections were cut from formalin-fixed, paraffin-embedded blocks, deparaffinized with xylene, and rehydrated by passages through decreasing concentrations of ethanol (100-80%). Endogenous peroxidase activity was blocked by a 30-minute incubation at room temperature with methanol containing 3% H 2 O 2 . Tissue sections were then incubated at 98jC for 40 minutes in citrate buffer (pH 6.0) for antigen retrieval (ChemMate, DAKO). After rinsing in Optimax Wash Buffer (Menarini Diagnostics, Firenze, Italy), tissue sections were incubated overnight at 4jC with optimal amounts of rabbit polyclonal anti-P2X 7 antibody raised against the synthetic peptide corresponding to the last 20 amino acids of the P2X 7 protein and kindly provided by Dr. Gary Buell (Serono, Geneva, Switzerland) or rabbit IgG isotype control (Southern Biotechnology Associates, Inc., Birmingham, AL) as negative controls. Tissue sections were washed twice in Optimax Wash Buffer and incubated for 30 minutes at room temperature with DAKO Envision System HRP Mouse. After washing in Optimax Wash Buffer, peroxidase activity was detected by incubating tissue sections for 6 to 10 minutes at room temperature with DAKO Liquid 3,3V -Diaminobenzidine Substrate Chromogen System (DAKO). Tissue sections were counterstained with Mayer's hematoxylin (Sigma, St. Louis, MO).
Serial tissue sections were stained with NB84 (DAKO) and CD45 monoclonal antibodies (mAb; UCHL1, DAKO) that detect neuroblasts and cells of hematopoietic origin, respectively. Areas containing at least 80% to 90% neuroblasts were selected for the analysis of P2X 7 expression. To this end, these areas were first inspected at low magnification and then carefully analyzed at higher magnification (Â63).The percentage of stained tumor cells in each lesion was evaluated independently by two investigators. The variation between the results obtained by these investigators was <10%. Results were scored as negative or positive when the percentage of stained tumor cells in each microscopic area was <25% or >25%, respectively. The inclusion of each tumor sample in one of the above scores was based on the score of the microscopic area containing the highest percentage of mAbpositive neuroblasts.
Cell lines and flow cytometry. The ACN, GI-ME-N, HTLA-230, GI-CA-N, LAN-5, LAN-1, SK-N-BE-2, and SH-SY-5Y human neuroblastoma cell lines and the human acute monocytic leukemia THP1 cell line were cultured in RPMI 1640 (Sigma) supplemented with L-glutamine, penicillin/ streptomycin, nonessential amino acids, and 10% fetal bovine serum (FBS; Sigma; complete medium). Phycoerythrin (PE)-conjugated AffiniPure F(abV ) 2 fragments of sheep anti-rabbit IgG antibodies were purchased from Serotec Ltd. (Oxford, United Kingdom). Intracellular staining of cell lines was done as described. Briefly, cells were washed thrice with PBS (Sigma) containing 1% FBS (staining buffer) and fixed with 2% paraformaldehyde at room temperature for 20 minutes. Then, cells were washed twice with staining buffer and incubated in permeabilization buffer (PBS, 1% FBS, and 0.1% saponin; Sigma) for 30 minutes at room temperature. Cells (5 Â 10 5 per tube) were next incubated with the primary rabbit polyclonal anti-P2X 7 antibody or rabbit IgG isotype control for 30 minutes at room temperature and then washed twice with permeabilization buffer and incubated with PE-conjugated F(abV ) 2 fragments of sheep anti-rabbit IgG antibodies for 20 minutes at room temperature. Cells were then washed twice in permeabilization buffer and resuspended in staining buffer before being analyzed by flow cytometry using a FACScan instrument (BD Biosciences, San Jose, CA). CellQuest software (BD Biosciences) was used for data analysis. The results of flow cytometry experiments are expressed as percentage of positive cells.
Immunofluorescence. Human neuroblastoma cell lines were seeded on glass slides, washed with PBS, and fixed with paraformaldehyde (2% in PBS). After washing with PBS, the slides were incubated with 100 mmol/L ammonium chloride for 20 minutes at 4jC. Then, the cells were permeabilized with Triton X-100 (0.1% in PBS) and blocked with human serum for 20 minutes at 4jC. After washing with PBS, the cells were incubated for 1 hour with polyclonal anti-P2X 7 antibody overnight at 4jC. Cells were then rinsed twice with PBS and incubated with a FITCconjugated AffiniPure F(abV ) 2 fragments of sheep anti-rabbit IgG antibodies for 30 minutes at 4jC. At the end of this incubation, slides were rinsed with PBS and analyzed with the fluorescence microscope (17) . (18) .
Semiquantitative measurement of plasma membrane potential. Changes in plasma membrane potential were measured in standard saline solution with the fluorescent dye bis-1,3-diethylthiobarbiturate trimethineoxonal (bisoxonol; Molecular Probes, Leiden, the Netherlands) at the wavelength pair 450/580 nm as described previously (18) . Briefly, cells at a concentration of 100,000/mL were incubated at 37jC in a fluorimeter cuvette with magnetic stirring in the presence of 100 nmol/L bisoxonol. Depolarization triggered by nucleotide addition is expressed as percent change of maximal fluorescence increase caused by the addition of 60 mmol/L KCl.
Changes in plasma membrane permeability. P2X 7 -mediated increases in plasma membrane permeability were measured by monitoring the uptake of the dye YO-PRO (Molecular Probes; ref. 17) . Cell monolayers were incubated for 15 minutes at 37jC in standard saline containing 10 Amol/L YO-PRO in the presence or absence of various nucleotides. After several washings to remove the extracellular dye, cells were analyzed with an inverted fluorescence microscope (Olympus IMT-2, Olympus Optical Co. Ltd., Tokyo, Japan) equipped with a Â40 objective and fluorescein filter.
Morphologic changes and assessment of apoptosis. Human neuroblastoma cells were cultured in six-well plates (Costar, Cambridge, MA) for 1, 2, 4, 6, 12, and 24 hours in the absence or presence of ATP in the range of 0.5 to 5 mmol/L. For each time, the cells were observed under a contrastphase microscope to evaluate morphologic changes and harvested by brief trypsinization. The proportion of apoptotic cells was assessed by flow cytometry using an Annexin V-FITC apoptosis kit according to the manufacturer's instruction (Bender MedSystems, Vienna, Austria). For measurement of caspase-3 activation, cells were seeded in 24-well plates at 37jC at a concentration of 200,000 per well in serum-free RPMI 1640 and stimulated with the various nucleotides for 4 hours. At the end of this incubation, cells were lysed and caspase-3 activation was measured fluorimetrically with a fluorescence-based kit as indicated by the manufacturer (Molecular Probes).
Assessment of proliferation. Cells were seeded at the concentration of 200,000 per well in 24-well plates in serum-free RPMI 1640 at 37jC. After 24 hours, cells were harvested and cell number was measured with the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) test (Molecular Probes). Results were validated by cell counting. In some experiments, cells were also treated with increasing different concentrations of substance P (e.g., Fig. 5 ).
Assessment of IL-1B and substance P secretion. For IL-1h measurement, cells were seeded in 24-well plates at 37jC at a concentration of 200,000 per well, primed with bacterial lipopolysaccharide, and stimulated with increasing nucleotide concentrations (100 Amol/L-5 mmol/L) for 30 minutes in serum-free RPMI 1640. At the end of this incubation time, supernatants were withdrawn and tested for IL-1h content by ELISA (R&D Systems, Minneapolis, MN). For substance P measurement, cell were incubated in serum-free RPMI 1640 and stimulated with the nucleotides for 2 hours. Substance P (Sigma) content of the supernatants was measured by ELISA (R&D Systems).
Results
P2X 7 receptor expression in primary human neuroblastoma tumors and cell lines. Paraffin-embedded tissue sections from newly diagnosed, Schwannian stroma poor, primary neuroblastoma were stained in the immunoperoxidase reaction with a rabbit polyclonal anti-P2X 7 antiserum. Figure 1A shows a representative experiment in which the majority of tumor cells in every lesion displayed an intense staining pattern. In Fig. 1B , a negative control stained with an isotype and subclass-matched irrelevant antibody is shown. Figure 1C shows the proportion of neuroblastoma tumors testing positive for P2X 7 receptor expression. The majority of the tumors showed robust P2X 7 expression irrespective of the pattern of disease presentation (i.e., localized or metastatic).
Expression of P2X 7 protein was next investigated in a panel of human neuroblastoma cell lines by flow cytometry. P2X 7 receptor was detected in the cytosol of all human neuroblastoma cell lines (Fig. 1D) . As shown in Fig. 1D (inset) , immunofluorescence microscopy analysis of ACN cells revealed clear P2X 7 patches at the level of the plasma membrane as well as diffuse cytosolic staining. The same staining pattern was obtained in the THP1 control cell line (data not shown), in agreement with previous data showing that most THP1 cells have a large cytoplasmic reservoir of P2X 7 (11) . These findings indicated that in both ACN and THP1 cells P2X 7 was expressed both in the transmembrane and in the cytoplasm.
Finally, expression of P2X 7 in human neuroblastoma cell lines was confirmed by Western blot experiments done with the same polyclonal antiserum used for fluorescence-activated cell sorting analysis and immunofluorescence microscopy (data not shown).
The above data show unambiguously that the P2X 7 protein is expressed in both primary neuroblastoma tumors and neuroblastoma cell lines.
Functional characterization of P2X 7 in human neuroblastoma cell lines. We next investigated the functional responses coupled to activation of P2X 7 in human neuroblastoma cell lines. Despite the presence of sulfinpyrazone, ACN cells showed a large spontaneous leakage of fura-2-AM, a finding not unusual in tumors cells ( Fig. 2A) . Both ATP and the ATP pharmacologic analogue benzoyl-ATP, which are known to induce Ca 2+ fluxes in many cells expressing the P2X 7 (5, 19) , triggered a massive [Ca 2+ ] i increase. The dose-dependent effect of ATP and benzoyl-ATP was biphasic, suggesting the activation of two different classes of P2 receptors, one with high affinity (ATP EC 50 in the 10 Amol/L range, presumably P2Y) and one with low affinity (ATP EC 50 of f1 mmol/L, presumably P2X 7 ). As mentioned, P2X 7 has two functional activation states: as a cation selective channel and, on sustained stimulation, as a nonselective pore (7) . One of the earliest changes due to P2X 7 activation is the collapse of plasma membrane potential due to the large Na + influx. As shown in Fig. 2B , ATP caused a large plasma membrane depolarization in ACN cells, with an EC 50 of f200 Amol/L. The more potent P2X 7 agonist benzoyl-ATP also caused plasma membrane potential collapse, but with a lower EC 50 (30 Amol/L; data not shown).
The hallmark of P2X 7 activation is an ATP-dependent permeabilization of the plasma membrane to large molecules, including the fluorescent dyes lucifer yellow, YO-PRO, and ethidium bromide (7, 20) . In Fig. 3 , we show the effect on YO-PRO uptake of treatment of ACN cells with 1 mmol/L ATP for 15 minutes. As shown in Fig. 3A , in the absence of the nucleotide, cells showed negligible dye uptake mainly due to fluid phase endocytosis. ATP caused a massive YO-PRO uptake by most cells (Fig. 3C) . Quite interestingly, and in agreement with observations done in other cell types (11) , ATP stimulation also caused plasma membrane blebbing and vesicle release into the extracellular space. Similar results were obtained in other neuroblastoma cell lines (data not shown).
The Ca 2+ /calmodulin-dependent protein kinase II inhibitor KN-62 has been proposed as a selective and potent antagonist for the human P2X 7 (21) . As shown in Fig. 3E , treatment with this inhibitor strongly reduced ATP-triggered YO-PRO uptake, a strong proof for the direct involvement of the P2X 7 in ATP-dependent plasma membrane permeabilization in ACN cells.
Cell proliferation and apoptosis induced by P2X 7 activation in human neuroblastoma cell lines. Activation of the P2X 7 caused striking and dose-dependent morphologic alterations in neuroblastoma cell lines. The earliest shape change was loss of neurites and cell shrinkage, already detectable in ACN cells at a concentration of 0.5 mmol/L ATP (Fig. 4A, b) . Such morphologic alterations were not observed in untreated ACN cells (Fig. 4A, a) .
At higher concentrations, plasma membrane blebbing also occurred in most ACN cells (Fig. 4A, c and d) . Very interestingly, all these changes were fully reversible on removal of ATP, and in contrast to most other cell types expressing P2X 7 (22) , no signs of apoptosis or necrosis were detected at any time as assessed by Annexin V staining (data not shown). Similar morphologic changes were observed in different neuroblastoma cell lines treated with ATP (data not shown).
Lack of P2X 7 -dependent cytotoxicity was further supported by the inability of ATP or benzoyl-ATP to activate caspase-3 in neuroblastoma cells (Fig. 4B) . In contrast, control rat mesangial cells, well known to have a strong P2X 7 -dependent caspase-3 activity (23), were dose-dependently stimulated on incubation with ATP or benzoyl-ATP (Fig. 4B) . Lack of an overt cytotoxic effect in neuroblastoma cells due to P2X 7 activation was surprising, because this receptor/pore is a well-known trigger of cell death. However, in some cell types, P2X 7 can act as a growth-promoting receptor (9, 13). To investigate this alternative function, we monitored neuroblastoma cell proliferation by the MTT assay following exposure to different stimuli. As shown in Fig. 5 , ATP at the optimal concentration of 0.5 mmol/L promoted ACN cell proliferation. However, the proliferative effect was not confined to ATP, but other nucleotides (e.g., benzoyl-ATP, UTP, ADP, and AMP) as well as adenosine promoted growth of ACN cells in the absence of serum. The two nucleotidehydrolyzing enzymes apyrase and hexokinase also promoted growth in the absence of added exogenous nucleotides. This indicates that the mechanism whereby extracellular nucleotides stimulate growth of ACN cells is complex, involving activation of P2X, P2Y, and P1 receptors. In addition, the growth-promoting effect of apyrase and hexokinase suggests that ACN cells continuously release into the pericellular space ATP that can be then converted to adenosine. In keeping with this interpretation, inactivation by boiling of the two enzymes suppressed growth stimulation (Fig. 5) . Measurement of ATP secretion by the standard soluble luciferase assay or by a recently developed plasma membrane-targeted chimeric luciferase showed that ACN maintain a resting pericellular ATP level in the 100 to 200 nmol/L range that increases up to 100 Amol/L on stimulation (24) . Similar results were obtained with other neuroblastoma cell lines (data not shown).
Substance P released on P2 receptor stimulation promotes neuroblastoma cell proliferation. Although direct activation of P2 and P1 receptors by nucleotides and adenosine can by itself support growth, it cannot be excluded that additional factors with growth-promoting activity are released by ACN cells on stimulation with nucleotides. In fact, it is well documented that P2Y and P2X 7 activation can induce release of trophic factors, such as tumor necrosis factor-a, IL-1h, and IL-6, in different cell types (17, 22, 25) . Therefore, we investigated whether stimulation with extracellular nucleotides can cause secretion of IL-1h and substance P, two molecules that can be produced by human neuroblastoma cell lines and regulate their growth (26, 27) . We were unable to detect IL-1h release from ACN cells under several experimental conditions (data not shown). On the contrary, a large release of substance P was triggered by ATP, benzoyl-ATP, and UTP (Fig. 6A ). Benzoyl-ATP was a better agonist that the other two nucleotides tested, suggesting a main role for the P2X 7 receptor (Fig. 6A) . Substance P secreted by ACN cells on stimulation was in the 150 to 400 pg/mL range; thus, we investigated whether this amount was sufficient to stimulate ACN cell growth. As shown in Fig. 6B , addition of substance P in the 100 to 300 pg/mL range caused almost a doubling of the ACN cell population. Similar results were obtained with other neuroblastoma cell lines (data not shown). These results show that P2 receptor activation in neuroblastoma cells triggers release of powerful paracrine/autocrine growth-promoting factors besides directly stimulating proliferation.
Discussion
Extracellular nucleotides have now acquired a full status of mediators of cell-to-cell communication (28) (29) (30) (31) .
The complexity of this extracellular messenger system is highlighted by the number of P2 receptor subtypes thus far identified and by their ubiquitous distribution. Furthermore, different nucleotide selectivity and affinity endow this system with a remarkable plasticity.
Among P2 receptors, P2X 7 is one of the most intriguing, owing to its ability to mediate plasma membrane permeabilization to low molecular mass aqueous solutes by an as yet poorly understood process. This permeabilization process is likely due to the opening of a nonselective pore that is generally thought to coincide with the receptor itself (7, 32) but that according to other investigators might be a separate molecular entity (33) .
Several tumors have been shown to express P2X 7 at unusually high levels (13, (34) (35) (36) (37) (38) . In some cases (i.e., breast and prostate cancer), it was suggested that the P2X 7 might be nonfunctional (36, 37) , but no data were presented to support this claim. In all other instances, tumor cells expressed fully functional P2X 7 .
In this study, we show for the first time that human neuroblastoma cells from either primary tumors or cell lines expressed P2X 7 receptors. The functionality of these receptors was shown by different assays, such as ligand-induced changes in free intracellular calcium concentrations, membrane depolarization, and uptake of the YO-PRO dye.
Among P2X receptors, only the P2X 7 subtype is able to cause a collapse of plasma membrane permeability barrier most likely through its extended COOH-terminal cytoplasmic tail that allows interaction with several intracellular proteins and possibly organelles (39) . The physiologic meaning of this phenomenon is basically unknown, but because plasma membrane pore formation is a common trigger of cell death, as epitomized by complement and several bacterial toxins, it is widely assumed that P2X 7 is a cytotoxic receptor.
We found that, on incubation with ATP or benzoyl-ATP, neuroblastoma cells underwent distinctive morphologic changes, including loss of neurites, swelling, and shrinkage, all suggestive of an ongoing apoptotic process. However, these phenomena were transient and no apoptosis of neuroblastoma cells was detected by either Annexin V assay or caspase-3 activation. These results showed that the latter cells were refractory to P2X 7 ligand-induced apoptosis and suggested that this behavior of tumor cells could represent a survival strategy.
Additional functions of P2X 7 unrelated to cytotoxicity have been identified, such as triggering of cell proliferation (9, 40) , cytokine release (41) (42) (43) , and transcription factor activation (44, 45) .
Two reports from some of us (P.C., S.F., and F.D.V.) have shown that overexpression of the P2X 7 provides a growth/survival advantage under limiting culture conditions (i.e., in the absence of serum-derived factors; refs. 9, 13).
Although the biochemical basis of this effect is as yet poorly understood, available evidence suggests that a small but significant elevation in cytoplasmic and intramitochondrial Ca 2+ levels plays a crucial role (43) . Thus, a tumor would be in a very favorable position if it could silence the negative (death inducing) responses linked to P2X 7 activation and keep only the positive (growth supporting).
We tested this hypothesis by investigating proliferation of neuroblastoma cells induced by P2X 7 ligands (i.e., ATP and the specific agonist benzoyl-ATP). The experiments done with the latter ligand allowed to conclude unambiguously that selective P2X 7 triggering resulted into an enhancement of neuroblastoma cell proliferation. At least part of this effect was found to depend on the induced release of substance P that stimulated in a dosedependent manner neuroblastoma cell growth. Substance P is a tachykinine family member that has an important role in inflammation and has been shown recently to promote neuroblastoma growth (27) .
Assignment of a functional role to receptors for extracellular nucleotides implies by necessity the presence of these molecules in the extracellular milieu. Therefore, an obvious, but as yet unproven, assumption is that in the tumor microenvironment there is enough extracellular ATP to activate P2 receptors, including the low-affinity P2X 7 . We have measured the extracellular ATP concentrations by the standard luciferin/luciferase assay or by a plasma membrane-targeted chimeric luciferase and found that ACN cells keep a steady ATP concentration in the incubation medium of 100 to 200 nmol/L (24), 3 a value f10-fold higher than that usually found in culture supernatants from different cell types (46) . With the availability of more sophisticated techniques, it is becoming clear that ATP is released into the extracellular milieu not only at sites of tissue damage but also in the perilesional regions (47) . Whether a high extracellular ATP concentration is also a feature of the neuroblastoma microenvironment is an open question that is currently the subject of active investigation.
In conclusion, neuroblastoma cells seem to have molded P2X 7 receptor function to their advantage in two ways: on the one hand, they have silenced P2X 7 cytotoxic activity by blocking its ability to turn on caspase-3 and, on the other, they have exploited P2X 7 capacity to trigger the release of locally acting trophic factors, like substance P. Based on these findings, it is tempting to speculate that targeted ATP inactivation in the tumor microenvironment may dampen tumor growth.
